OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aerobic exercise elicits clinical adaptations in myotonic dystrophy type 1 patients independently of pathophysiological changes
Andrew I. Mikhail, Péter L. Nagy, Katherine Manta, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 10
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial
Charles A. Thornton, Richard T. Moxley, Katy Eichinger, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 3, pp. 218-228
Closed Access | Times Cited: 28

Skeletal muscle disorders as risk factors for type 2 diabetes.
Eshwar R. Tammineni, Carlo Manno, Goldie Oza, et al.
Molecular and Cellular Endocrinology (2025), pp. 112466-112466
Open Access | Times Cited: 1

SnoRNAs in cardiovascular development, function, and disease
Alzbeta Chabronova, Terri L. Holmes, Duc M. Hoang, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 6, pp. 562-578
Open Access | Times Cited: 5

Myotonic Dystrophy
Johanna Hamel
CONTINUUM Lifelong Learning in Neurology (2022) Vol. 28, Iss. 6, pp. 1715-1734
Closed Access | Times Cited: 19

A single dose of exercise stimulates skeletal muscle mitochondrial plasticity in myotonic dystrophy type 1
Andrew I. Mikhail, Alexander Manta, Sean Y. Ng, et al.
Acta Physiologica (2023) Vol. 237, Iss. 4
Open Access | Times Cited: 12

AMPK is mitochondrial medicine for neuromuscular disorders
Andrew I. Mikhail, Sean Y. Ng, Stephanie R. Mattina, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 7, pp. 512-529
Open Access | Times Cited: 11

Diagnosis and Management of Myotonic Dystrophy Type 1
J Hartman, Tejal Patki, Nicholas Johnson
JAMA (2024) Vol. 331, Iss. 14, pp. 1227-1227
Closed Access | Times Cited: 3

Revealing myopathy spectrum: integrating transcriptional and clinical features of human skeletal muscles with varying health conditions
Huahua Zhong, Veronica Sian, Mridul Johari, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 3

Small non‐coding RNA profiling in patients with gastrointestinal cancer
Alessio Molfino, Marc Beltrà, Maria Ida Amabile, et al.
Journal of Cachexia Sarcopenia and Muscle (2023) Vol. 14, Iss. 6, pp. 2692-2702
Open Access | Times Cited: 8

Individual transcriptomic response to strength training for patients with myotonic dystrophy type 1
Emily E Davey, Cécilia Légaré, Lori Planco, et al.
JCI Insight (2023) Vol. 8, Iss. 14
Open Access | Times Cited: 8

Resistance Exercise Training Rescues Mitochondrial Dysfunction in Skeletal Muscle of Patients with Myotonic Dystrophy Type 1
Valeria Di Leo, Conor Lawless, Marie‐Pier Roussel, et al.
Journal of Neuromuscular Diseases (2023) Vol. 10, Iss. 6, pp. 1111-1126
Open Access | Times Cited: 7

Resistance training in women with DM1: a multisystemic therapeutic avenue
Laura Girard-Côté, Benjamin Gallais, Cynthia Gagnon, et al.
Neuromuscular Disorders (2024) Vol. 40, pp. 38-51
Open Access | Times Cited: 2

Combinatorial treatment with exercise and AICAR potentiates the rescue of myotonic dystrophy type 1 mouse muscles in a sex-specific manner
Naomi S Misquitta, Aymeric Ravel‐Chapuis, Bernard J. Jasmin
Human Molecular Genetics (2022) Vol. 32, Iss. 4, pp. 551-566
Closed Access | Times Cited: 10

Mitochondrial Dysfunction in Repeat Expansion Diseases
Alberto Giménez-Bejarano, Eva Alegre-Cortés, Sokhna M. S. Yakhine-Diop, et al.
Antioxidants (2023) Vol. 12, Iss. 8, pp. 1593-1593
Open Access | Times Cited: 6

Pharmacological and exercise‐induced activation of AMPK as emerging therapies for myotonic dystrophy type 1 patients
Aymeric Ravel‐Chapuis, Élise Duchesne, Bernard J. Jasmin
The Journal of Physiology (2022) Vol. 600, Iss. 14, pp. 3249-3264
Closed Access | Times Cited: 9

The bi-directional relationship between sleep and inflammation in muscular dystrophies: A narrative review
Niamh Mahon, Jeffrey Glennon
Neuroscience & Biobehavioral Reviews (2023) Vol. 150, pp. 105116-105116
Open Access | Times Cited: 4

Effets de l’exercice physique sur les maladies musculaires
Alexis Boulinguiez, Dounia Bouragba, Bárbara Crisol, et al.
médecine/sciences (2024) Vol. 40, pp. 17-21
Closed Access | Times Cited: 1

FSHD Therapeutic Strategies: What Will It Take to Get to Clinic?
Charis L. Himeda, Peter L. Jones
Journal of Personalized Medicine (2022) Vol. 12, Iss. 6, pp. 865-865
Open Access | Times Cited: 7

Benefits of aerobic exercise in myotonic dystrophy type 1
Samuel Mackenzie, Johanna Hamel, Charles A. Thornton
Journal of Clinical Investigation (2022) Vol. 132, Iss. 10
Open Access | Times Cited: 6

Energy Expenditure, Body Composition, and Skeletal Muscle Oxidative Capacity in Patients with Myotonic Dystrophy Type 1
Isis B.T. Joosten, Cas J. Fuchs, Milou Beelen, et al.
Journal of Neuromuscular Diseases (2023) Vol. 10, Iss. 4, pp. 701-712
Open Access | Times Cited: 3

Effectiveness of conservative non-pharmacological interventions in people with muscular dystrophies: a systematic review and meta-analysis
Enza Leone, Anand Pandyan, Alison Rogers, et al.
Journal of Neurology Neurosurgery & Psychiatry (2023), pp. jnnp-331988
Open Access | Times Cited: 2

Combinatorial therapies for rescuing myotonic dystrophy type 1 skeletal muscle defects
Aymeric Ravel‐Chapuis, Bernard J. Jasmin
Trends in Molecular Medicine (2022) Vol. 28, Iss. 6, pp. 439-442
Closed Access | Times Cited: 4

Strength training rescues mitochondrial dysfunction in skeletal muscle of patients with myotonic dystrophy type 1
Valeria Di Leo, Conor Lawless, Marie-Pier Roussel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2

Intellectual profile in myotonic dystrophy type 1 and its association with its onset: a systematic review and meta-analysis
Carlos Pascual‐Morena, Iván Cavero‐Redondo, Alicia Saz‐Lara, et al.
Pediatric Neurology (2024) Vol. 161, pp. 9-17
Closed Access

Page 1 - Next Page

Scroll to top